Literature DB >> 7825685

Corneal lipidosis in patients with the acquired immunodeficiency syndrome.

K R Wilhelmus1, M J Keener, D B Jones, R L Font.   

Abstract

PURPOSE: Certain drugs bind to anionic phospholipids of lysosomal membranes and produce progressive intracellular accumulation of lamellar inclusions. We studied two patients treated for opportunistic infections associated with the acquired immunodeficiency syndrome (AIDS), who developed bilateral ocular surface changes suggestive of drug-induced corneal lipidosis.
METHODS: Two patients with AIDS had translucent vacuoles within the corneal epithelium and mild conjunctival hyperemia. Because the differential diagnosis included microsporidial keratoconjunctivitis, biopsies of the ocular surface were performed for histopathologic analysis.
RESULTS: Transmission electron microscopy of corneal epithelial debridement and conjunctival biopsy specimens showed intracellular, electron-dense lipoidal bodies and multilaminated lysosomal inclusions suggestive of a drug-induced lipidosis. Both patients also had tubuloreticular inclusions in conjunctival capillary endothelial cells. The ocular surface changes resolved within one to three months after dosage reduction or discontinuation of systemic ganciclovir and acyclovir.
CONCLUSIONS: Drug-induced phospholipidosis is a cause of punctate corneal epitheliopathy during AIDS, but the responsible agent remains to be identified.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7825685     DOI: 10.1016/s0002-9394(14)73808-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  2 in total

1.  Ultrastructural features and prevalence of tubuloreticular structures in the ocular vasculature of patients with AIDS: a study of 23 cases.

Authors:  R K Maturi; R L Font
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

2.  HIF-1α is essential for effective PMN bacterial killing, antimicrobial peptide production and apoptosis in Pseudomonas aeruginosa keratitis.

Authors:  Elizabeth A Berger; Sharon A McClellan; Kerry S Vistisen; Linda D Hazlett
Journal:  PLoS Pathog       Date:  2013-07-18       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.